advertisement
Kim SJ 24
Showing records 1 to 24 |
Display all abstracts from Kim SJ106446 Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of CancerAhmed A
Biomolecules 2022; 12:
106667 Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of OphthalmologySit AJ
Ophthalmology 2023; 130: 433-442
106332 Fatty Liver Is an Independent Risk Factor for Elevated Intraocular PressureLee JH
Nutrients 2022; 14:
106667 Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of OphthalmologyChen TC
Ophthalmology 2023; 130: 433-442
106332 Fatty Liver Is an Independent Risk Factor for Elevated Intraocular PressureKwon YJ
Nutrients 2022; 14:
106446 Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of CancerAziz M
Biomolecules 2022; 12:
106332 Fatty Liver Is an Independent Risk Factor for Elevated Intraocular PressureLee HS
Nutrients 2022; 14:
106446 Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of CancerEjaz SA
Biomolecules 2022; 12:
106667 Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of OphthalmologyTakusagawa HL
Ophthalmology 2023; 130: 433-442
106332 Fatty Liver Is an Independent Risk Factor for Elevated Intraocular PressureHan JH
Nutrients 2022; 14:
106667 Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of OphthalmologyRosdahl JA
Ophthalmology 2023; 130: 433-442
106446 Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of CancerChannar PA
Biomolecules 2022; 12:
106667 Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of OphthalmologyHoguet A
Ophthalmology 2023; 130: 433-442
106332 Fatty Liver Is an Independent Risk Factor for Elevated Intraocular PressureJoung B
Nutrients 2022; 14:
106446 Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of CancerSaeed A
Biomolecules 2022; 12:
106667 Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of OphthalmologyChopra V
Ophthalmology 2023; 130: 433-442
106446 Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of CancerZargar S
Biomolecules 2022; 12:
106332 Fatty Liver Is an Independent Risk Factor for Elevated Intraocular PressureKim SJ
Nutrients 2022; 14:
106667 Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of OphthalmologyRichter GM
Ophthalmology 2023; 130: 433-442
106446 Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of CancerWani TA; Hamad A
Biomolecules 2022; 12:
106667 Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of OphthalmologyOu Y
Ophthalmology 2023; 130: 433-442
106446 Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of CancerAbbas Q
Biomolecules 2022; 12:
106667 Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of OphthalmologyKim SJ; WuDunn D
Ophthalmology 2023; 130: 433-442
106446 Design, Synthesis, Kinetic Analysis and Pharmacophore-Directed Discovery of 3-Ethylaniline Hybrid Imino-Thiazolidinone as Potential Inhibitor of Carbonic Anhydrase II: An Emerging Biological Target for Treatment of CancerRaza H; Kim SJ
Biomolecules 2022; 12:
Issue 23-3
Change Issue
advertisement